616 related articles for article (PubMed ID: 23603023)
1. Targeting intracellular compartments by magnetic polymeric nanoparticles.
Kocbek P; Kralj S; Kreft ME; Kristl J
Eur J Pharm Sci; 2013 Sep; 50(1):130-8. PubMed ID: 23603023
[TBL] [Abstract][Full Text] [Related]
2. Folate-targeting magnetic core-shell nanocarriers for selective drug release and imaging.
Wang H; Wang S; Liao Z; Zhao P; Su W; Niu R; Chang J
Int J Pharm; 2012 Jul; 430(1-2):342-9. PubMed ID: 22525087
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin.
Li F; Sun J; Zhu H; Wen X; Lin C; Shi D
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):58-62. PubMed ID: 21764271
[TBL] [Abstract][Full Text] [Related]
4. AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.
Aravind A; Jeyamohan P; Nair R; Veeranarayanan S; Nagaoka Y; Yoshida Y; Maekawa T; Kumar DS
Biotechnol Bioeng; 2012 Nov; 109(11):2920-31. PubMed ID: 22615073
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of superparamagnetic iron oxide/doxorubicin co-loaded poly (lactic-co-glycolic acid) nanospheres prepared by different emulsion solvent evaporation methods.
Mosafer J; Teymouri M
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1146-1155. PubMed ID: 28789586
[TBL] [Abstract][Full Text] [Related]
6. Polymeric-gold nanohybrids for combined imaging and cancer therapy.
Topete A; Alatorre-Meda M; Villar-Alvarez EM; Carregal-Romero S; Barbosa S; Parak WJ; Taboada P; Mosquera V
Adv Healthc Mater; 2014 Aug; 3(8):1309-25. PubMed ID: 24764284
[TBL] [Abstract][Full Text] [Related]
7. Multimodal imaging of nanovaccine carriers targeted to human dendritic cells.
Cruz LJ; Tacken PJ; Bonetto F; Buschow SI; Croes HJ; Wijers M; de Vries IJ; Figdor CG
Mol Pharm; 2011 Apr; 8(2):520-31. PubMed ID: 21381651
[TBL] [Abstract][Full Text] [Related]
8. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
10. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
Niu X; Zou W; Liu C; Zhang N; Fu C
Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
[TBL] [Abstract][Full Text] [Related]
11. Active brain targeting of a fluorescent P-gp substrate using polymeric magnetic nanocarrier system.
Kirthivasan B; Singh D; Bommana MM; Raut SL; Squillante E; Sadoqi M
Nanotechnology; 2012 Jun; 23(25):255102. PubMed ID: 22652439
[TBL] [Abstract][Full Text] [Related]
12. Co-association of methotrexate and SPIONs into anti-CD64 antibody-conjugated PLGA nanoparticles for theranostic application.
Moura CC; Segundo MA; Neves Jd; Reis S; Sarmento B
Int J Nanomedicine; 2014; 9():4911-22. PubMed ID: 25364249
[TBL] [Abstract][Full Text] [Related]
13. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody.
Kocbek P; Obermajer N; Cegnar M; Kos J; Kristl J
J Control Release; 2007 Jul; 120(1-2):18-26. PubMed ID: 17509712
[TBL] [Abstract][Full Text] [Related]
14. Surface functionalized magnetic nanoparticles shift cell behavior with on/off magnetic fields.
Jeon S; Subbiah R; Bonaedy T; Van S; Park K; Yun K
J Cell Physiol; 2018 Feb; 233(2):1168-1178. PubMed ID: 28464242
[TBL] [Abstract][Full Text] [Related]
15. cRGD-functionalized polymeric magnetic nanoparticles as a dual-drug delivery system for safe targeted cancer therapy.
Shen JM; Gao FY; Yin T; Zhang HX; Ma M; Yang YJ; Yue F
Pharmacol Res; 2013 Apr; 70(1):102-15. PubMed ID: 23376353
[TBL] [Abstract][Full Text] [Related]
16. The combined magnetic field and iron oxide-PLGA composite particles: Effective protein antigen delivery and immune stimulation in dendritic cells.
Saengruengrit C; Ritprajak P; Wanichwecharungruang S; Sharma A; Salvan G; Zahn DRT; Insin N
J Colloid Interface Sci; 2018 Jun; 520():101-111. PubMed ID: 29529457
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
[TBL] [Abstract][Full Text] [Related]
18. Construction and evaluation of Fe₃O₄-based PLGA nanoparticles carrying rtPA used in the detection of thrombosis and in targeted thrombolysis.
Zhou J; Guo D; Zhang Y; Wu W; Ran H; Wang Z
ACS Appl Mater Interfaces; 2014 Apr; 6(8):5566-76. PubMed ID: 24693875
[TBL] [Abstract][Full Text] [Related]
19. Encapsulation of superparamagnetic iron oxide nanoparticles in poly-(lactide-co-glycolic acid) microspheres for biomedical applications.
Gun S; Edirisinghe M; Stride E
Mater Sci Eng C Mater Biol Appl; 2013 Aug; 33(6):3129-37. PubMed ID: 23706192
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures.
Costantino L; Gandolfi F; Bossy-Nobs L; Tosi G; Gurny R; Rivasi F; Vandelli MA; Forni F
Biomaterials; 2006 Sep; 27(26):4635-45. PubMed ID: 16716395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
